{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T06:45:10Z","timestamp":1785912310360,"version":"3.56.0"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["K08NS092895"],"award-info":[{"award-number":["K08NS092895"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Leptomeningeal metastasis from a solid tumor carries a dismal prognosis with median survival of 3-5 months after diagnosis and treatment with external beam radiation therapy. It targets the whole-brain or the entire central nervous system depending on disease extent, and is the current standard therapeutic approach, however, its effectiveness is limited by insufficient cytotoxicity and severe off target radiotoxicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Radiopharmaceutical therapy is a promising strategy to deliver therapeutic radiation doses directly to the leptomeningeal space while minimizing damage to the normal central nervous system tissue. In this study, the tumor targeting alkylphosphocholine (NM600) was radiolabeled with 177Lu for SPECT\/CT imaging and 225Ac for therapeutic efficacy in the context of solid tumor leptomeningeal metastasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In in vitro experiments 225Ac-NM600 induced significantly greater apoptosis, reduced colony formation, and increased expression of DNA damage markers, compared to 177Lu or external beam radiation. In vivo therapeutic and toxicity profiles were assessed in leptomeningeal metastasis models of triple negative breast cancer and non-small cell lung cancer in NSG mice. Intrathecal administration of 177Lu- or 225Ac-NM600 demonstrated excellent tumor targeting with minimal off target effect, confirmed by SPECT\/CT imaging and ex vivo biodistribution. 225Ac-NM600 was well tolerated, inhibited tumor growth, and significantly improved overall survival in both models. Moreover, central nervous system radiotoxicity was markedly lower with 225Ac-NM600 RPT compared to external beam radiation therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Compared with whole brain external beam radiation therapy, 225Ac-NM600 provides superior anti-tumor efficacy and reduced off target toxicity supporting its further evaluation in clinical trial.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/neuonc\/noag098","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:57:06Z","timestamp":1777377426000},"page":"1986-1998","source":"Crossref","is-referenced-by-count":0,"title":["Radiopharmaceutical therapy provides superior survival advantage for leptomeningeal metastasis compared to external beam radiotherapy"],"prefix":"10.1093","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1178-1183","authenticated-orcid":false,"given":"Lei","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, University of Wisconsin School of Medicine & Public Health, UW Carbone Cancer Center , Madison, Wisconsin,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1608-1146","authenticated-orcid":false,"given":"Paul A","family":"Clark","sequence":"additional","affiliation":[{"name":"Department of Human Oncology, University of Wisconsin School of Medicine & Public Health, UW Carbone Cancer Center , Madison, Wisconsin,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5088-7805","authenticated-orcid":false,"given":"Jack M","family":"Shireman","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Wisconsin School of Medicine & Public Health, UW Carbone Cancer Center , Madison, Wisconsin,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheyenne L","family":"Schepp","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Wisconsin School of Medicine & Public Health, UW Carbone Cancer Center , Madison, Wisconsin,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4933-6428","authenticated-orcid":false,"given":"Hansel Comas","family":"Rojas","sequence":"additional","affiliation":[{"name":"Department of Medical Physics, University of Wisconsin School of Medicine & Public Health, UW Carbone Cancer Center , Madison, Wisconsin,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0334-105X","authenticated-orcid":false,"given":"Ohyun","family":"Kwon","sequence":"additional","affiliation":[{"name":"Department of Medical Physics, University of Wisconsin School of Medicine & Public Health, UW Carbone Cancer Center , Madison, Wisconsin,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5096-4865","authenticated-orcid":false,"given":"Adedamola O","family":"Adeniyi","sequence":"additional","affiliation":[{"name":"Department of Medical Physics, University of Wisconsin School of Medicine & Public Health, UW Carbone Cancer Center , Madison, Wisconsin,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0437-6668","authenticated-orcid":false,"given":"Malick Bio","family":"Idrissou","sequence":"additional","affiliation":[{"name":"Department of Medical Physics, University of Wisconsin School of Medicine & Public Health, UW Carbone Cancer Center , Madison, Wisconsin,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2389-9229","authenticated-orcid":false,"given":"Caroline P","family":"Kerr","sequence":"additional","affiliation":[{"name":"Department of Human Oncology, University of Wisconsin School of Medicine & Public Health, UW Carbone Cancer Center , Madison, Wisconsin,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Iskandar","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Wisconsin School of Medicine & Public Health, UW Carbone Cancer Center , Madison, Wisconsin,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farheen","family":"Chowdhury","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Wisconsin School of Medicine & Public Health, UW Carbone Cancer Center , Madison, Wisconsin,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5959-4061","authenticated-orcid":false,"given":"Xiaohu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Wisconsin School of Medicine & Public Health, UW Carbone Cancer Center , Madison, Wisconsin,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0729-2179","authenticated-orcid":false,"given":"Reinier","family":"Hernandez","sequence":"additional","affiliation":[{"name":"Department of Medical Physics, University of Wisconsin School of Medicine & Public Health, UW Carbone Cancer Center , Madison, Wisconsin,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7467-9816","authenticated-orcid":false,"given":"Bryan","family":"Bednarz","sequence":"additional","affiliation":[{"name":"Department of Medical Physics, University of Wisconsin School of Medicine & Public Health, UW Carbone Cancer Center , Madison, Wisconsin,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2048-6381","authenticated-orcid":false,"given":"Jamey P","family":"Weichert","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Wisconsin School of Medicine & Public Health, UW Carbone Cancer Center , Madison, Wisconsin,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5558-3547","authenticated-orcid":false,"given":"Zachary S","family":"Morris","sequence":"additional","affiliation":[{"name":"Department of Human Oncology, University of Wisconsin School of Medicine & Public Health, UW Carbone Cancer Center , Madison, Wisconsin,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7024-5164","authenticated-orcid":false,"given":"Mahua","family":"Dey","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Wisconsin School of Medicine & Public Health, UW Carbone Cancer Center , Madison, Wisconsin,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,2]]},"reference":[{"key":"2026080501512459300_noag098-B1","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1016\/S1470-2045(17)30689-7","article-title":"Leptomeningeal metastases in non-small-cell lung cancer","volume":"19","author":"Cheng","year":"2018","journal-title":"Lancet Oncol."},{"key":"2026080501512459300_noag098-B2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13122888","article-title":"Leptomeningeal metastases from solid tumors: recent advances in diagnosis and molecular approaches","volume":"13","author":"Pellerino","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026080501512459300_noag098-B3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030685","article-title":"The evolving landscape of leptomeningeal cancer from solid tumors: a systematic review of clinical trials","volume":"15","author":"Marenco-Hillembrand","year":"2023","journal-title":"Cancers (Basel)"},{"key":"2026080501512459300_noag098-B4","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","article-title":"Breast cancer","volume":"5","author":"Harbeck","year":"2019","journal-title":"Nat Rev Dis Primers."},{"key":"2026080501512459300_noag098-B5","doi-asserted-by":"publisher","first-page":"S265","DOI":"10.4103\/2152-7806.111304","article-title":"Carcinomatous meningitis: leptomeningeal metastases in solid tumors","volume":"4","author":"Le Rhun","year":"2013","journal-title":"Surg Neurol Int"},{"key":"2026080501512459300_noag098-B6","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1158\/1535-7163.MCT-21-0140","article-title":"A novel brain-permeant chemotherapeutic agent for the treatment of brain metastasis in Triple-Negative breast cancer","volume":"20","author":"Deng","year":"2021","journal-title":"Mol Cancer Ther."},{"key":"2026080501512459300_noag098-B7","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.1200\/JCO.22.01148","article-title":"Randomized phase II trial of proton craniospinal irradiation versus photon Involved-Field radiotherapy for patients with solid tumor leptomeningeal metastasis","volume":"40","author":"Yang","year":"2022","journal-title":"J Clin Oncol."},{"key":"2026080501512459300_noag098-B8","doi-asserted-by":"publisher","first-page":"vdae034","DOI":"10.1093\/noajnl\/vdae034","article-title":"Proton versus photon craniospinal irradiation for adult medulloblastoma: a dosimetric, toxicity, and exploratory cost analysis","volume":"6","author":"Breen","year":"2024","journal-title":"Neurooncol Adv."},{"key":"2026080501512459300_noag098-B9","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1007\/s12094-021-02615-8","article-title":"A systematic review of craniospinal irradiation for leptomeningeal disease: past, present, and future","volume":"23","author":"Maillie","year":"2021","journal-title":"Clin Transl Oncol."},{"key":"2026080501512459300_noag098-B10","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1001\/jamaoncol.2025.3007","article-title":"Proton craniospinal irradiation for patients with leptomeningeal metastasis: a randomized clinical trial","volume":"11","author":"Yang","year":"2025","journal-title":"JAMA Oncol."},{"key":"2026080501512459300_noag098-B11","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.prro.2025.03.015","article-title":"Real-World experience using proton versus photon craniospinal irradiation for leptomeningeal disease","volume":"15","author":"Frechette","year":"2025","journal-title":"Pract Radiat Oncol."},{"key":"2026080501512459300_noag098-B12","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1038\/s41467-025-57263-1","article-title":"Convection enhanced delivery of rhenium ((186)Re) obisbemeda ((186)RNL) in recurrent glioma: a multicenter, single arm, phase 1 clinical trial","volume":"16","author":"Brenner","year":"2025","journal-title":"Nat Commun."},{"key":"2026080501512459300_noag098-B13","doi-asserted-by":"publisher","first-page":"240ra75","DOI":"10.1126\/scitranslmed.3007646","article-title":"Alkylphosphocholine analogs for broad-spectrum cancer imaging and therapy","volume":"6","author":"Weichert","year":"2014","journal-title":"Sci Transl Med."},{"key":"2026080501512459300_noag098-B14","doi-asserted-by":"publisher","first-page":"244","DOI":"10.2967\/jnumed.117.193748","article-title":"Targeted molecular radiotherapy of pediatric solid tumors using a radioiodinated alkyl-phospholipid ether analog","volume":"59","author":"Baiu","year":"2018","journal-title":"J Nucl Med."},{"key":"2026080501512459300_noag098-B15","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abb3631","article-title":"Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade","volume":"13","author":"Patel","year":"2021","journal-title":"Sci Transl Med."},{"key":"2026080501512459300_noag098-B16","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.2967\/jnumed.119.236265","article-title":"Lu-NM600 targeted radionuclide therapy extends survival in syngeneic murine models of triple-negative breast cancer","volume":"61","author":"Hernandez","year":"2020","journal-title":"J Nucl Med."},{"key":"2026080501512459300_noag098-B17","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.2967\/jnumed.118.224808","article-title":"Preclinical characterization of (86\/90)Y-NM600 in a variety of murine and human cancer tumor models","volume":"60","author":"Grudzinski","year":"2019","journal-title":"J Nucl Med."},{"key":"2026080501512459300_noag098-B18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s42003-019-0327-4","article-title":"90)Y-NM600 targeted radionuclide therapy induces immunologic memory in syngeneic models of T-cell non-Hodgkin\u2019s lymphoma","volume":"2","author":"Hernandez","year":"2019","journal-title":"Commun Biol."},{"key":"2026080501512459300_noag098-B19","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/s41573-020-0085-5","article-title":"Author correction: radiopharmaceutical therapy in cancer: clinical advances and challenges","volume":"19","author":"Sgouros","year":"2020","journal-title":"Nat Rev Drug Discov."},{"key":"2026080501512459300_noag098-B20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11060-024-04654-x","article-title":"Repurposing mebendazole against triple-negative breast cancer CNS metastasis","volume":"168","author":"Rodrigues","year":"2024","journal-title":"J Neurooncol."},{"key":"2026080501512459300_noag098-B21","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1158\/2326-6066.CIR-24-1191","article-title":"The effects of clinically relevant radionuclides on the activation of an IFN1 response correlate with radionuclide half-life and linear energy transfer and influence radiopharmaceutical antitumor efficacy","volume":"13","author":"Kerr","year":"2025","journal-title":"Cancer Immunol Res."},{"key":"2026080501512459300_noag098-B22","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13014-019-1268-2","article-title":"Development and characterisation of acquired radioresistant breast cancer cell lines","volume":"14","author":"Gray","year":"2019","journal-title":"Radiat Oncol."},{"key":"2026080501512459300_noag098-B23","doi-asserted-by":"publisher","first-page":"723801","DOI":"10.3389\/fcell.2021.723801","article-title":"Iron-Dependent autophagic cell death induced by radiation in MDA-MB-231 breast cancer cells","volume":"9","author":"Ma","year":"2021","journal-title":"Front Cell Dev Biol."},{"key":"2026080501512459300_noag098-B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-026-68834-1","article-title":"Priming versus propagating: distinct immune effects of alpha- versus beta-particle emitting radiopharmaceuticals when combined with immune checkpoint inhibition in mice","volume":"17","author":"Kerr","year":"2026","journal-title":"Nat Commun."},{"key":"2026080501512459300_noag098-B25","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1667\/RADE-20-00237.1","article-title":"Low-dose radiation potentiates the propagation of anti-tumor immunity against melanoma tumor in the brain after In situ vaccination at a tumor outside the brain","volume":"195","author":"Clark","year":"2021","journal-title":"Radiat Res."},{"key":"2026080501512459300_noag098-B26","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16010191","article-title":"Comparative study of the effect of radiation delivered by lutetium-177 or actinium-225 on anti-GD2 chimeric antigen receptor T cell viability and functions","volume":"16","author":"Sodji","year":"2023","journal-title":"Cancers (Basel)"},{"key":"2026080501512459300_noag098-B27","doi-asserted-by":"publisher","first-page":"eade8732","DOI":"10.1126\/scitranslmed.ade8732","article-title":"Gene-edited and -engineered stem cell platform drives immunotherapy for brain metastatic melanomas","volume":"15","author":"Kanaya","year":"2023","journal-title":"Sci Transl Med."},{"key":"2026080501512459300_noag098-B28","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics."},{"key":"2026080501512459300_noag098-B29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2164-10-22","article-title":"BioMart\u2014biological queries made easy","volume":"10","author":"Smedley","year":"2009","journal-title":"BMC Genomics."},{"key":"2026080501512459300_noag098-B30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16203459","article-title":"CCL21 induces plasmacytoid dendritic cell migration and activation in a mouse model of glioblastoma","volume":"16","author":"Zhao","year":"2024","journal-title":"Cancers (Basel)"},{"key":"2026080501512459300_noag098-B31","doi-asserted-by":"publisher","first-page":"e13864","DOI":"10.1111\/acel.13864","article-title":"GM-CSF and IL-7 fusion cytokine engineered tumor vaccine generates long-term Th-17 memory cells and increases overall survival in aged syngeneic mouse models of glioblastoma","volume":"22","author":"Shireman","year":"2023","journal-title":"Aging Cell."},{"key":"2026080501512459300_noag098-B32","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.cell.2017.02.025","article-title":"Complement component 3 adapts the cerebrospinal fluid for leptomeningeal metastasis","volume":"168","author":"Boire","year":"2017","journal-title":"Cell."},{"key":"2026080501512459300_noag098-B33","doi-asserted-by":"publisher","first-page":"6120","DOI":"10.7150\/thno.54881","article-title":"Temporal analysis of type 1 interferon activation in tumor cells following external beam radiotherapy or targeted radionuclide therapy","volume":"11","author":"Jagodinsky","year":"2021","journal-title":"Theranostics."},{"key":"2026080501512459300_noag098-B34","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.it.2016.12.004","article-title":"Crosstalk between cytoplasmic RIG-I and STING sensing pathways","volume":"38","author":"Zevini","year":"2017","journal-title":"Trends Immunol."},{"key":"2026080501512459300_noag098-B35","doi-asserted-by":"publisher","first-page":"116706","DOI":"10.1016\/j.jns.2020.116706","article-title":"Leptomeningeal metastasis from solid tumors","volume":"411","author":"Thakkar","year":"2020","journal-title":"J Neurol Sci."},{"key":"2026080501512459300_noag098-B36","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41568-024-00700-y","article-title":"The path to leptomeningeal metastasis","volume":"24","author":"Remsik","year":"2024","journal-title":"Nat Rev Cancer."},{"key":"2026080501512459300_noag098-B37","doi-asserted-by":"publisher","first-page":"eadh5548","DOI":"10.1126\/science.adh5548","article-title":"Breast cancer exploits neural signaling pathways for bone-to-meninges metastasis","volume":"384","author":"Whiteley","year":"2024","journal-title":"Science."},{"key":"2026080501512459300_noag098-B38","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1667\/RR14346.1","article-title":"Ionizing radiation induces innate immune responses in macrophages by generation of mitochondrial reactive oxygen species","volume":"187","author":"Kim","year":"2017","journal-title":"Radiat Res."},{"key":"2026080501512459300_noag098-B39","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.semradonc.2014.07.008","article-title":"Myeloid-derived cells in tumors: effects of radiation","volume":"25","author":"Vatner","year":"2015","journal-title":"Semin Radiat Oncol."},{"key":"2026080501512459300_noag098-B40","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1172\/JCI58644","article-title":"Innate immunity in the Central nervous system","volume":"122","author":"Ransohoff","year":"2012","journal-title":"J Clin Invest."},{"key":"2026080501512459300_noag098-B41","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41586-024-07461-6","article-title":"Covalent targeted radioligands potentiate radionuclide therapy","volume":"630","author":"Cui","year":"2024","journal-title":"Nature."},{"key":"2026080501512459300_noag098-B42","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1001\/jamaoncol.2018.4044","article-title":"Targeted alpha therapy, an emerging class of cancer agents: a review","volume":"4","author":"Targeted Alpha Therapy Working","year":"2018","journal-title":"JAMA Oncol"},{"key":"2026080501512459300_noag098-B43","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.addr.2015.12.003","article-title":"Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting alpha-particles or auger electrons","volume":"109","author":"Aghevlian","year":"2017","journal-title":"Adv Drug Deliv Rev."},{"key":"2026080501512459300_noag098-B44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186602","article-title":"Comparison of high- and low-LET radiation-induced DNA double-strand break processing in living cells","volume":"21","author":"Roobol","year":"2020","journal-title":"Int J Mol Sci."},{"key":"2026080501512459300_noag098-B45","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1126\/science.1088845","article-title":"Dynamics of DNA double-strand breaks revealed by clustering of damaged chromosome domains","volume":"303","author":"Aten","year":"2004","journal-title":"Science."},{"key":"2026080501512459300_noag098-B46","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1053\/j.semnuclmed.2008.05.002","article-title":"Therapeutic radionuclides: biophysical and radiobiologic principles","volume":"38","author":"Kassis","year":"2008","journal-title":"Semin Nucl Med."},{"key":"2026080501512459300_noag098-B47","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20212121","article-title":"The anatomic basis of leptomeningeal metastasis","volume":"221","author":"Freret","year":"2024","journal-title":"J Exp Med."},{"key":"2026080501512459300_noag098-B48","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s00259-025-07390-0","article-title":"Targeted alpha therapy: a comprehensive analysis of the biological effects from \u201clocal-regional-systemic\u201d dimensions","volume":"53","author":"Song","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026080501512459300_noag098-B49","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11090450","article-title":"Combination of proton therapy and radionuclide therapy in mice: preclinical pilot study at the Paul scherrer institute","volume":"11","author":"M\u00fcller","year":"2019","journal-title":"Pharmaceutics."},{"key":"2026080501512459300_noag098-B50","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14215293","article-title":"Re-Whole brain radiotherapy may Be one of the treatment choices for symptomatic brain metastases patients","volume":"14","author":"Ono","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2026080501512459300_noag098-B51","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13236086","article-title":"Dose-response effect and dose-toxicity in stereotactic radiotherapy for brain metastases: a review","volume":"13","author":"Loo","year":"2021","journal-title":"Cancers (Basel)"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noag098\/68207612\/noag098.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/28\/8\/1986\/68207612\/noag098.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/28\/8\/1986\/68207612\/noag098.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:51:37Z","timestamp":1785909097000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/28\/8\/1986\/8666938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,2]]},"references-count":51,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,5,2]]},"published-print":{"date-parts":[[2026,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noag098","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,5,2]]}}}